Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Please explain the conflicting statements that 40% recurrence of TNBC and the statement About one-quarter of people with TNBC will have a recurrence.

September 3
 · 
Be the first to react
How Fast Does Triple-Negative Cancer Grow? 4 Reasons It’s Aggressive Read Article...
MyBCTeam

Great question! Those two percentages refer to different types of breast cancer, so it's important to understand the distinction.

The 40% recurrence rate applies to triple-negative breast cancer (TNBC). This subtype tends to be more aggressive and is more likely to return, often within the first three years after Show Full Answer

Great question! Those two percentages refer to different types of breast cancer, so it's important to understand the distinction.

The 40% recurrence rate applies to triple-negative breast cancer (TNBC). This subtype tends to be more aggressive and is more likely to return, often within the first three years after treatment.

The other percentage you may be referring to relates to hormone receptor-positive (HR-positive) breast cancer that had spread to the lymph nodes, where roughly 1 in 6 people (about 17%) experienced recurrence within five years. Here's a quick breakdown by type:

- Triple-negative breast cancer: ~40% recurrence rate, often within 3 years
- Inflammatory breast cancer: ~50% recurrence within the first 5 years
- HR-positive breast cancer (with lymph node involvement): ~1 in 6 within 5 years

It's worth noting that recurrence risk is highly individual. Factors like tumor size, stage, age at diagnosis, and how well treatment worked all play a role.

Talking with your oncologist about your specific subtype and personal risk factors will give you the clearest picture of what these numbers mean for you.

September 3

Related Questions

View All